Imaging Agents Market Trends 2022


Pune, India, August 10, 2022 (GLOBE NEWSWIRE) —

The global imaging agent market size is estimated to grow exponentially over the forecast period, driven by the growing demand for innovative imaging machines. Devices like computed tomography (CT) and magnetic resonance imaging (MRI) are widely used by medical professionals to obtain detailed images of tissues and bones for better diagnosis. Below are some of the major trends increasing the size of the global industry during the period 2022-2028:

  • Europe (regional valuation will exceed USD 3.3 billion by 2028)

Iodinated contrast products will be widely used in imaging machines:

Europe Imaging Agents Market Revenue from iodinated contrast media reached USD 1 billion in 2021 due to robust use of CT and X-ray machines. Non-ionic stable iodine imaging agents are also readily available, which can improve the quality of diagnosis.

Angioplasty procedures are increasing at an alarming rate across the region due to the presence of a large geriatric population. According to the British Heart Foundation, approximately 250,000 coronary angiograms are performed in the UK each year. Iodinated contrast agents are used in a variety of indications, such as neurological, nephrological, gastrointestinal, cardiovascular, musculoskeletal and cancer.

Go to sample pages of the report, “Europe Imaging Agents Market Forecast 2028” in detail with the table of contents (ToC) @

Role of imaging agents in cardiology applications:

The cardiology segment captured 30% of the European industry share in 2021 owing to the rising incidence of cardiovascular disease (CVD) in the region. According to the European Heart Network, nearly 3.9 million patients die of cardiovascular disease in Europe alone, while the European Union (EU) records 1.8 million deaths each year. Frequent smokers are exposed to different types of pollutants, which increase their risk of contracting cardiovascular diseases. Unhealthy lifestyles will fuel the need for imaging agents to screen potential patients.

CT scanners will increasingly rely on imaging agents:

The CT segment held more than 25.6% of the imaging agent market share in Europe in 2021. Contrast agents used in CT scans are responsible for developing high-quality 3D structural images. CT procedures primarily use iodinated and barium-based contrast media. When imaging agents, such as iodine and barium, are injected into a patient’s body, they block x-rays, creating detailed images of organs, blood cells and other tissues. These qualities will increase the demand for CT scanners to enable high quality diagnosis.

  • Asia-Pacific (regional valuation to exceed USD 2.7 billion by 2028)

The increase in neurological diseases amplifies the adoption of imaging devices:

Asia-Pacific Imaging Agents Market Size in the neurology segment will exhibit a CAGR of 5.2% through 2028, as the region experiences a worrying rise in Alzheimer’s disease cases. According to the Alzheimer’s and Related Disorders Society of India (ARDSI), in 2020, around 5.3 million people over the age of 60 were diagnosed with dementia in India.

Molecular imaging is preferred in such cases as it can offer detailed images of the body at molecular and cellular levels. Positron emission tomography (PET) and single photon emission tomography (SPECT) are some of the imaging tools primarily used to detect physiological changes, which can help identify central nervous system disorders.

Go to sample pages of the report, “Asia-Pacific Imaging Agents Market Forecast 2028” in detail with the table of contents (ToC) @

The demand for MRI machines is increasing:

MRI segment will capture approximately 13.6% of APAC industry share by 2028. Magnetic Resonance Imaging (MRI) is a non-invasive imaging technology that scans and generates detailed images of organs and fabrics. It is commonly used to detect brain injuries, multiple sclerosis, epilepsy, strokes and infections in specialized centers and diagnostic laboratories. Product sales will increase as MRI machines rely on imaging agents to accurately detect and diagnose a medical condition.

Hospitals will increase the use of imaging agents:

Hospitals held over 42% market share in Asia-Pacific in 2021 owing to the increasing use of innovative diagnostic technologies to detect and diagnose various diseases. The comprehensive network of hospitals is also growing at a noticeable pace in the region.

Hospital emergency rooms provide high quality care to patients who have experienced extreme health conditions, such as excessive bleeding, strokes, trauma and dangerous infections, which has led to the adoption imaging agents to accurately diagnose these problems.

  • North America (regional valuation expected to exceed USD 4.6 billion by 2028)

X-ray procedures will increase to improve the diagnosis of diseases:

North America Imaging Agents Market Size X-ray machines will observe a CAGR of 4.7% through 2028. X-ray machines are one of the most valuable medical tools as they are used to perform a wide range of procedures and examinations. The COVID-19 pandemic greatly increased the use of x-ray machines as they were useful in detecting COVID-related lesions in a patient’s lungs.

Go to sample pages of the report, “North America Imaging Agents Market Forecast 2028” in detail with the table of contents (ToC) @

Gadolinium-based contrast products will be used in MRI machines:

North America gadolinium-based contrast media market revenue reached USD 458 million in 2021. MRI machines are widely used to generate detailed images of tissues and organs. The region is witnessing a dramatic increase in cases of multiple sclerosis, brain tumors, strokes, traumatic brain injury and epilepsy, further boosting the demand for gadolinium-based contrast media.

About Graph Search:

“Graphical Research” provides an extensive collection of market research and industry analysis reports covering healthcare, automotive, oil and gas, pharmaceutical, IT, agriculture, chemicals and many other sectors, in various regions like North America, Europe, Asia-Pacific, America, and others. The comprehensive reports we provide are aligned with key industry trends and insights into specific regional markets. The data we provide helps our clients make better strategic decisions. Our goal is to offer competitive and quality custom market research reports.


Source link


Comments are closed.